Eupraxia Pharmaceuticals Reports Six-Month Symptom Data From The Highest Dose Cohort In Its Ongoing Phase 1B/2A RESOLVE Trial In Eosinophilic Esophagitis

President revealing congressman’s terminal diagnosis follows caginess about his own health, such as recent rash When Donald Trump revealed that Republican congressman Neal Dunn would have been “dead by June” if not for White House doctors who treated the representative’s reportedly terminal condition, many were shocked by his disclosure. The president’s comments last week, which unfolded during a meandering presser with Republican House speaker Mike Johnson and Kennedy Center leaders, came after

Here are four perspectives from providers, patients, life science executives and healthcare technologists about ways to boost trust at a time of rapid AI deployments. The post How to Boost Trust in Tech? 4 Perspectives from SXSW appeared first on MedCity News .

Cancer research was a major focus of the night's event.

Reader letters to Newsday.